September 9-12, 2019
Boston Convention and Exhibition Center (BCEC),
Fast-tracking your next generation cell and gene therapies through ground breaking bioprocessing, manufacturing & supply chain strategies
World renowned leaders share the latest technologies & commercialization techniques to revolutionize your cell, gene and CAR-T clinical and late stage programs
NEWS FLASH: BRAND NEW 2019 CONTENT
Clinical and Early Stage CAR T Cell and Gene Therapy Advances
- Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
- Transition technologies from bench to bedside: CRISPR, Exosomes and more..
- Understand how to build a sustainable process early on for optimum clinical translation
Cell and Gene Therapy Bioprocessing
- Build a strategy for monitoring quality across your process with PAT and automated analytics
- Get to grips with technologies and novel platforms for efficient upstream and downstream processes
- Simplify manufacturing automation and prepare for commercialization
Cell & Gene Therapy Commercialization
- Work towards industry 4.0 – integrating manufacturing and delivery into healthcare
- Optimise the way you work with external partners to drive commercialization
- Ensure profitability with forward thinking in facility design and scalability strategies
Supply Chain Barriers: Upstream and Downstream Considerations
- Improve confidence in your raw material supply chain – vectors, risk mitigation and more
- Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
- Prepare for successful delivery to patients & supply chain scale up
Cell and Gene Therapy Connect – Partnering Track
- Keep abreast of the evolving landscape of cell and gene therapies
- Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more
- Dive into pharmacoeconomic approaches to reimbursement
Bio fabrication – The Path to Commercialization: With ARMI
In collaboration with our event partners ARMI (Advanced Regenerative Manufacturing Institute) we will be bringing you an exciting day jam packed with content on making practical the large-scale manufacturing of engineered tissues and tissue-related technologies, to benefit existing industries and grow new ones.
Stay tuned for more updates soon.
WHICH ONE WOULD YOU CONSIDER YOURSELF TO BE....?
I am a Pioneer
- An innovator who has been in the industry since conception and wants to put theory into practice
Why should I attend?
- Hear from small emerging biotechs who are pitching big ideas
- Hear from small emerging biotech's who are pitching big ideas
- Benchmark, network & meet peers and tech providers through the one-to-one meeting tool
I am STILL LEARNING
- Fairly new to the cell and gene therapy community with previous experience with MAb's and other modalities
Why should I attend?
- Hear how the industry think to apply my experience in the space
- Understand the industry landscape and where the gaps lie
- Have the opportunity for exposure, collaboration and success
I am a PROBLEM SOLVER
- I bring thought leadership to the table I have a clear definition of what the industry issues are
Why should I attend?
- Get access to all the key stakeholders in industry
- Gain authority in the field through building my personal brand
- Get an unrivaled opportunity to present cutting edge scientific data
2018 Number Crunching
A week-long series of free webinars with live Q&A continues to connect cell and gene therapy leaders throughout the year from the comfort of your desk, hear the latest updates from leading industry speakers and gain an insight into some of the most innovative topics and research.
Don't miss out this year's DIGITAL WEEK: 8-11 APRIL 2019
WHY YOU SHOULD ATTEND:
Benchmark against your peers
Therapeutic developers face real challenges with regards to scaling up, establishing safe and reproducible manufacturing and supply chains as well as pricing and reimbursement – make sure you aren’t the one being left behind.
The process is the product
How you manufacture your product can sink or swim your business. What’s the point in building a product that costs more to make than it does to sell, or is only stable for 8hrs when it takes 10hrs to get it from the patient to the manufacturing facility?
Be a Leader
Companies continue to partner and work together in developing novel approaches to rare diseases – are you one of the ones driving the industry forward?
Sponsorship and Exhibition Opportunities
Highlight your company's expertise to a global audience of cell and gene therapy scientists and decision makers. A wide variety of options are available to accommodate your company's goals and budget.